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chloralose (80 mg/kg) and sodium pentobarbitone (5 mg/kg). Ventilation through a tracheostomy was controlled using a Starling pump delivering air in a tidal volume of approximately 8 mllkg at a rate of 20 breaths/minute to maintain arterial Peo2 in the range 25-35 mmHg.
The tibia and femur of one leg were held rigid by bone pins, and the tendon of tibialis anterior was connected to a Grass FT03C force transducer with a resting tension of 50 g. The ipsilateral sciatic nerve was divided and the distal portion stimulated at 0.06 Hz with a single square-wave impulse of 0.2 ms duration and supramaximal voltage. Twitch height was recorded on a Beckman RB Dynograph. Blood pressure was recorded continuously from a carotid artery using a Statham P23DC pressure transducer. A cannula was placed in a jugular vein and connected to a motorised syringe pump for infusion of drugs. Another cannula was inserted into a femoral vein for bolus injections of drugs and fluids.
Intravenous fluid (40,70 dextrose N/5 saline) was given at 5 ml/kg per hour except during .·~/we'>(linl(l and Itlfcl/\il't! Carc, ~ "()f. X . . \(). 3 . ...tutU\{, J1) 8] ANOMALOUS ACTION OF TUBOCURARINE 253 drug infusions. Body heat was conserved by use of insulation, radiant heat, and warmed intravenous fluids. Rectal temperature was measured hourly. Arterial blood gases and serum electrolytes, urea and creatinine were measured before and after the experimental period.
Tubocurarine (Burroughs Wellcome) was infused at 20 J..Ig/kg per min and in all cases an increase in twitch height occurred. In 10 cats on 12 separate occasions the infusion was stopped when potentiation had reached a plateau over 60 s. Subsequently the duration of this potentiation was observed. On eight occasions the infusion was continued throughout the period of potentiation until twitch height decreased and tubocurarine administration was then stopped. In most cases the infusion was repeated some hours later following complete recovery of twitch height.
Perturbation of the potentiation was attempted on four occasions by varying the frequency of indirect stimulation. A frequencyresponse test was run using one-minute periods of higher frequency stimulation, namely 0.25, 0.5, 1.0 and 2.0 Hz. Each one minute period was followed by one minute at the baseline stimulation of 0.06 Hz. The maximal response during the one minute's stimulation was -Slow intravenous infusion (20 I'g/kg per min) of tubocurarine invariably resulted in an increase in twitch height in tibialis anterior of the cat, the muscle being stimulated indirectly via the sciatic nerve. In (a) the response was so dramatic that the amplification had to be reduced by half (0). In (b) the response was approximately a 30070 increase, commencing 2 minutes after the infusion was switched on. A resting tension of 50 g was applied to the muscle. The frequency of stimulation was 0.06 Hz, using a single square wave impulse of 0.2 ms duration and supramaximal voltage. measured, whether this response occurred during or at the end of the one minute. The frequency-response test was always run first in ascending order and then immediately in descending order.
Statistical Analysis. Results are given as mean and standard deviation. Statistical analysis was by Student's t-test. (20 / Ag/kg per min) produced an increase in twitch height (potentiation) ( Figure 1 , Table 1 ). The initial increase in twitch height was usually seen within two minutes of the infusion being commenced (that is, after only 40 /Ag/kg of tubocurarine had been administered), and contraction was generally maximal within 9 minutes (that is, after approximately 180 /Ag/kg). The magnitude of the increase was very variable between animals, from 5!J!o to 133!J!o with a mean of 36!J!o ( Table 1 ). If the infusion was ceased when maximum contraction was attained, the potentiation persisted for 84-120 min ( Table 1 , I), the potentiation slowly decaying towards pretreatment twitch height.
RESULTS

Slow intravenous infusion of tubocurarine
During the slow tubocurarine infusion there was a small decrease in mean arterial pressure of 3 mmHg (range -14 to + 5). The degree of potentiation was unrelated to the blood pressure change. At the commencement of potentiation, P02 was 99 mmHg (SD = 7.6, n = 13) and PC02 30 mmHg (SD = 3.6, n = 13).
Plasma electrolytes were in the normal range previously reported. 5 d·Te On Off FIGURE 2-S1ow intravenous infusion (20 Ilg/kg per min) of tubocurarine resulted in potentiation of twitch height followed by neuromuscular block. When the infusion was ceased potentiation was again evident. A resting tension of 50 g was applied to tibialis anterior, which was indirectly stimulated via the sciatic nerve, at 0.06 Hz using a single square wave impulse of 0.2 ms duration and supramaximal voltage. Figure 2 shows the typical pattern obtained when the infusion was continued after maximum potentiation was attained. As the infusion continued, potentiation decreased, and neuromuscular blockade appeared, with twitch height less than control (Table 2, 1). On cessation of infusion, potentiation re-emerged ( Figure 2 and Table 2 , I). This strongly suggests that the potentiation was related to plasma and tissue concentrations of tubocurarine.
In four cats, a frequency-response test was conducted in an attempt to perturb the potentiation. Conducting the frequencyresponse curve during the period of potentiation markedly decreased the duration ANOMALOUS ACTION OF TUBOCURARINE 255 of the potentiation from 97 to 43 min ( Table 1) . As seen in Table 3 and Figure 3 , in the presence of tubocurarine potentiation there is an upward, parallel shift of the frequencyresponse curve compared with that obtained under control conditions. The data in Table 3 is subdivided into the response to the change in stimulation conducted as an increase in rate and the response with the series given in reverse order (that is, a decrease in rate). The series of increase in frequency was always conducted first, the result being that the mean twitch height at the beginning of the first series expressed as a percentage of control was 141070 (SD 26.2) compared with 118% (SD 21.2) at the end of the second series.
Neuromuscular blockade was produced in these same animals by further infusion of tubocurarine at the same rate used to produce potentiation (20 J.lg/kg per min). When blockade had been produced (that is, twitch height less than 100%), the infusion rate was reduced to give a stable degree of block (5-8 J.lg/kg per min).5 During blockade, the frequency-response curve was repeated (Table 3, Figure 3 ). Increase in frequency was accompanied by an apparent increase in blockade at all frequencies. In two of the cats, after ceasing the infusion, there was evidence of re-emergence of marked potentiation. This is shown in Figure 3 , illustrated as a further frequency-response curve (curve 4).
DISCUSSION
In the present investigation a low dose infusion of tubocurarine invariably caused an increase in twitch response which, if the infusion was then stopped, was sustained for 84-120 minutes. If instead the infusion was continued, the preparation passed from potentiation into block. Termination of the infusion at this stage often resulted in a rebound potentiation, supporting the view that the presence of potentiation or block is dosedependent.
It is generally believed that tubocurarine causes neuromuscular blockade by a postjunctional action, specifically prevention of transmitter access to cholinergic receptors on the motor end plate. However, this theory has been challenged by the demonstration of reduced transmitter output in the presence of *mean and SD of 4 cats. tmean and SD of 3 cats. One animal reverted from blockade to potentiation during second part (Figure 3 ). tubocurarine,4 and there is not universal agreement concerning the relative importance of pre-and post -junctional events. 6 • 7 Moreover, several studies in vitro have demonstrated an increase in twitch tension at low concentrations of nondepolarising drugs. 4 . 8 -lo In man, intravenous Injection of tubocurarine in doses of 0.2-0.4 mg/kg causes paralysis within 3-4 min, with systemic hypotension the principal side-effect. However, response to the drug is variable. 11 For this reason, and to obviate severe hypotension at a time when the cardiovascular system is stressed by other drugs and procedures, it is usual to administer the drug incrementally. Despite this, transient potentiation of neuromuscular conduction has not been seen clinically. In routine anaesthesia indirect stimulation may be carried out during maintenance of anaesthesia or during attempted reversal of blockade with anticholinesterases. The increasing interest in mechanical and electromyographic monitoring of neuromuscular blockade during anaesthesia l2 should serve to clarify whether this effect occurs in man. One study reports the effects of 1.0 mg increments of tubocurarine on twitch tension in man during barbiturate, nitrous oxide, narcotic anaesthesia. 13 Though the authors have not commented on the observation their results suggest an initial increase in twitch tension at the lower doses.
The mechanism by which tubocurarine in low concentrations increased twitch response in the cat is unknown. One explanation is an increase in transmitter release. This effect has been noted with tubocurarine in vitro,4 with gallamine ill vivo,I4 and with pancuronium in vitro. 2 Hubbard et al. 3 using the rat phrenic nerve-diaphragm preparation, observed an increase in mean quantum size in the washout period following exposure to tubocurarine. Cholinergic receptors are present on the nerve terminalis and though their function has not been elucidated they may be important in transmitter mobilisation or release. 16 a-bungarotoxin blocks postjunctional acetylcholine receptors, and also enhances transmitter release in the rat hemidiaphragm. 17 Tubocurarine may act similarly in concentrations at which postjunctional function is unaffected due to the "margin of safety" at that site. This action on the nerve terminal may be competitive, and this possibility is supported by the abbreviation of potentiation by increasing stimulus frequency (Table 1 ) and by upward parallel shift of the frequency-response curve (Figure 3 ). We suggest that small doses of tubocurarine block negative feedback receptors on the nerve terminal. Further support for this hypothesis would come from the finding of repetitive nerve action potentials, increased quantal release of acetylcholine, and repetitive firing of the muscle fibres. Alternative mechanisms include increased end-plate sensitivity and repetitive firing of muscle fibres, or an effect on muscle membrane.
This hypothesis, however, must be reconciled with the decrease in transmitter output which has been reported at blocking concentrations of tubocurarine. One possibility is the existence of two populations of prejunctional receptors with opposing effects on acetylcholine release and different affinities for curare. Such a system could form a basis for feedback regulation of transmitter release, analogous to that believed to occur at noradrenergic nerve endings. 18 It may also account for apparent inconsistencies in published data on the effect of cholinergic agonists on the nerve terminal 19 and for differences between nondepolarising drugs in prejunctional activity.20
